Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease

Published:2020-10 Issue:5 Volume:2 Page:100137
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Sinha Rohit,Lockman Khalida A.,Homer Natalie Z.M.,Bower Edward,Brinkman Paul,Knobel Hugo H.,Fallowfield Jonathan A.,Jaap Alan J.,Hayes Peter C.,Plevris John N.

Funder

Edinburgh and Lothian Health Foundation

Diabetes Clinical Research Fund

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference42 articles.

1. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

2. Liver biopsy;Rockey;Hepatology,2009

3. Isoprene in the exhaled breath is a novel biomarker for advanced fibrosis in patients with chronic liver disease: a pilot study;Alkhouri;Clin Transl Gastroenterol,2015

4. Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls;Alkhouri;Pediatr Obes,2015

5. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis;Hanouneh;Clin Gastroenterol Hepatol,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The breath volatilome is shaped by the gut microbiota;2024-08-03

2. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review;International Journal of Molecular Sciences;2024-08-02

3. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform;Metabolomics;2024-07-08

4. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients;Clinica Chimica Acta;2024-03

5. Breath biomarkers in Non-Carcinogenic diseases;Clinica Chimica Acta;2024-01